Brief: Tiger Study Reports New TTFields Therapy Survival Results For Newly Diagnosed Glioblastoma Patients In Germany

NovoCure

23/05/2024 23:56

May 23 (Reuters) - Novocure Ltd  NVCR.O :
    * TIGER STUDY REPORTS NEW TTFIELDS THERAPY SURVIVAL RESULTS
FOR
NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS IN GERMANY
    * NOVOCURE LTD - OUTCOMES OBSERVED IN TIGER STUDY ARE
CONSISTENT
WITH SURVIVAL AND SAFETY RESULTS FROM NOVOCURE'S PHASE 3 EF-14
CLINICAL TRIAL

Source text for Eikon:  ID:nBw3HzbSva 
Further company coverage:  NVCR.O 

 ((Reuters.Briefs@thomsonreuters.com;))